Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.13% | 14.12% | -3.15% | -23.93% | 12.43% |
| Total Depreciation and Amortization | -0.31% | -5.61% | -0.64% | 13.78% | 26.46% |
| Total Amortization of Deferred Charges | 1.75% | 3.51% | 1.72% | -14.49% | 9.62% |
| Total Other Non-Cash Items | 17.86% | 25.85% | 31.69% | 33.37% | 27.69% |
| Change in Net Operating Assets | 299.78% | -176.00% | -336.73% | -108.01% | 65.53% |
| Cash from Operations | 26.71% | -26.14% | -210.32% | -43.84% | 55.64% |
| Capital Expenditure | -119.82% | -35.19% | 71.09% | 14.40% | 55.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.43% | 183.58% | 98.91% | 123.96% | 11.57% |
| Cash from Investing | 49.50% | 190.55% | 98.49% | 122.67% | 13.51% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 720.79% | -- | -99.06% | -90.28% | 1.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 720.79% | -- | -99.06% | -89.28% | -94.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.05% | 149.06% | -321.57% | 102.16% | -271.87% |
